Teva Announces European Medicines Agency (EMA) Confirms Successful Validation of Reslizumab Marketing Authorization Application
July 28, 2015 at 08:11 AM EDT
Teva Pharmaceutical Industries Ltd., (NYSE: TEVA) today announced that it has successfully filed a Marketing Authorization Application ...
